KMT2D and neoplasm: As KMT2D is a predicted tumor driver gene in ALL [19] and it overexpressed in ALL, when KMT2D is knocked down, it significantly decreased leukemia cell growth, promoted cell apoptosis, and inhibited cell proliferation.